查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760989

全球核醫放射性同位素市場

Nuclear Medicine Radioisotope
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球核醫放射性同位素市場規模將達到 166 億美元

全球核醫放射性同位素市場規模預計在2024年為106億美元，到2030年將達到166億美元，在2024-2030年的分析期間內，複合年成長率為7.8%。Technetium-99m（Tc-99m）是本報告分析的細分市場之一，預計其複合年成長率為8.7%，到分析期結束時將達到117億美元。鉈-201（Tl-201）細分市場在分析期間的複合年成長率預計為6.2%。

美國市場規模估計為 30 億美元，中國市場預期複合年成長率為 7.1%

美國核醫放射性同位素市場規模預計2024年達到30億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到25億美元，在2024-2030年的分析期間內，複合年成長率為7.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.4%和6.2%。在歐洲，預計德國市場的複合年成長率約為6.2%。

全球核醫學放射性同位素市場—主要趨勢與促進因素摘要

什麼是核醫放射性同位素？為什麼它們很重要？

核子醫學放射性同位素是用於診斷影像和治療的放射性物質，主要用於腫瘤學、心臟病學和神經病學領域。這些同位素會發出輻射，使醫生能夠拍攝器官、組織和骨骼的詳細影像，有助於檢測癌症、心臟病和阿茲海默症症等疾病。常見的放射性同位素包括用於診斷成像的Technetium-99m（Tc-99m）和用於治療甲狀腺癌的碘-131。放射性同位素在核子醫學中發揮重要作用，因為它們可以實現PET和SPECT掃描等非侵入性成像技術，因此無需手術即可提供高度準確的診斷。放射性藥物等治療應用可以進行標靶治療，最大限度地減少對健康組織的損害，從而改善患者的預後。

技術創新如何影響核醫放射性同位素市場？

放射性藥物和同位素生產技術的進步正在顯著影響核醫放射性同位素市場。先進迴旋加速器和核子反應爐的發展提高了放射性同位素生產的效率和安全性。此外，隨著醫療保健系統尋求降低與核子反應爐相關的風險並確保穩定的供應，對替代生產方法的研究也日益增多，例如無需核子反應爐即可生產Technetium-99m。放射性藥物配方的進步也使得放射性同位素的標靶性更加精準，從而提高了診斷的準確性和治療效果。此外，人工智慧 (AI) 正被應用於核醫學，以改善影像分析，使臨床醫生能夠更快、更準確地做出診斷。

疾病模式和消費行為的改變如何影響對放射性同位素的需求？

慢性病，尤其是癌症和心血管疾病的盛行率不斷上升，推動了全球對核醫放射性同位素的需求。隨著全球癌症診斷率的上升，放射性同位素在早期發現和標靶治療中發揮關鍵作用。隨著患者和醫療保健提供者越來越重視非侵入性診斷工具和個人化治療計劃，消費行為也正在影響市場。在先進醫療技術更容易獲得的地區，核醫學正在被納入標準醫療保健實踐。此外，世界人口老化推動了對核子醫學在診斷和治療與老齡化相關的疾病（如失智症和退化性心臟疾病）方面的需求。隨著患者對核醫學認知的提高，對高品質、快速診斷解決方案的需求也增加。

核醫學放射性同位素市場的成長受多種因素驅動

核醫學放射性同位素市場的成長受到多種因素的推動，包括技術進步、醫療保健需求的不斷成長以及放射性藥物的日益普及。迴旋加速器技術和放射性藥物的創新提高了放射性同位素的安全性、準確性和可用性，從而擴大了其在醫學影像和癌症治療中的應用。癌症和心血管疾病等慢性疾病的流行是診斷影像和治療應用的主要驅動力，從而推動了對Technetium-99m和碘-131等特定同位素的需求。此外，個人化醫療的轉變正在擴大標靶放射性同位素治療的應用，這種治療方案療效更佳，副作用更少。政府（尤其是在新興市場）支持核醫基礎設施的舉措，以及醫院PET和SPECT掃描儀的日益普及，也對市場發展做出了重大貢獻。最後，供應鏈的改進，包括非反應器同位素生產方法的開發，正在使醫用同位素更加可靠和永續性，從而進一步刺激市場擴張。

部分

放射性同位素類型（Technetium-99m（Tc-99m）、鉈-201（Tl-201）、鎵-67（Ga-67）、碘（I-123）、其他類型的放射性同位素）；用途（心臟病學、腫瘤學、神經病學、淋巴瘤、甲狀腺、其他用途）

受訪公司範例（42家值得關注的公司）

  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • NTP Radioisotopes SOC Ltd.
  • Positron Corporation
  • Siemens Healthineers

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自全球領域專家的精選內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13634

Global Nuclear Medicine Radioisotope Market to Reach US$16.6 Billion by 2030

The global market for Nuclear Medicine Radioisotope estimated at US$10.6 Billion in the year 2024, is expected to reach US$16.6 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Thallium-201 (Tl-201) segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 7.1% CAGR

The Nuclear Medicine Radioisotope market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Nuclear Medicine Radioisotope Market - Key Trends & Drivers Summarized

What Are Nuclear Medicine Radioisotopes and Why Are They Important?

Nuclear medicine radioisotopes are radioactive substances used in diagnostic imaging and therapeutic treatments, primarily in the field of oncology, cardiology, and neurology. These isotopes emit radiation that allows doctors to capture detailed images of organs, tissues, and bones, aiding in the detection of diseases such as cancer, heart disease, and Alzheimer’s. Common radioisotopes include Technetium-99m (Tc-99m) for diagnostic imaging and Iodine-131 for treating thyroid cancer. Radioisotopes play a critical role in nuclear medicine because they enable non-invasive imaging techniques, such as PET and SPECT scans, providing high-precision diagnostics without the need for surgery. Their therapeutic applications, such as radiopharmaceuticals, allow for targeted treatments that minimize damage to healthy tissue, enhancing patient outcomes.

How Are Technological Innovations Shaping the Nuclear Medicine Radioisotope Market?

Technological advancements in radiopharmacy and isotope production are significantly shaping the nuclear medicine radioisotope market. The development of advanced cyclotrons and nuclear reactors has improved the efficiency and safety of radioisotope production. Additionally, research into alternative production methods, such as non-reactor-based generation of Technetium-99m, is gaining momentum as healthcare systems seek to mitigate the risks associated with nuclear reactors and ensure a stable supply. Advancements in radiopharmaceutical formulations have also allowed for more precise targeting of radioisotopes, enhancing both the diagnostic accuracy and therapeutic efficacy of treatments. Furthermore, artificial intelligence (AI) is being integrated into nuclear medicine to improve image analysis, allowing clinicians to make faster and more accurate diagnoses.

How Are Changing Disease Patterns and Consumer Behavior Impacting Demand for Radioisotopes?

The increasing prevalence of chronic diseases, particularly cancer and cardiovascular conditions, is driving global demand for nuclear medicine radioisotopes. With cancer diagnoses rising worldwide, radioisotopes are playing a critical role in both early detection and targeted therapies. Consumer behavior is also influencing the market, as patients and healthcare providers increasingly prioritize non-invasive diagnostic tools and personalized treatment plans. In regions where access to advanced medical technologies is expanding, nuclear medicine is becoming more integrated into standard healthcare practices. Additionally, an aging global population is creating greater demand for nuclear medicine in the diagnosis and treatment of age-related diseases, such as dementia and degenerative heart conditions. As patient awareness of nuclear medicine grows, so does the demand for high-quality, fast-acting diagnostic solutions.

Growth in the Nuclear Medicine Radioisotope Market Is Driven by Several Factors

The growth in the nuclear medicine radioisotope market is driven by several factors, including technological advancements, evolving healthcare needs, and the increasing adoption of radiopharmaceuticals. Innovations in cyclotron technology and radiopharmaceuticals are improving the safety, precision, and availability of radioisotopes, which is encouraging wider use in medical imaging and cancer therapies. The growing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a major driver for diagnostic imaging and therapeutic applications, pushing demand for specific isotopes like Technetium-99m and Iodine-131. Additionally, the shift toward personalized medicine is expanding the use of targeted radioisotope therapies, which offer more effective treatment outcomes with fewer side effects. Government initiatives supporting nuclear medicine infrastructure, particularly in developing regions, and the increasing availability of PET and SPECT scanning devices in hospitals are also significant contributors to market growth. Finally, supply chain improvements, including the development of non-reactor-based isotope production methods, are ensuring a more reliable and sustainable supply of medical isotopes, further fueling the market’s expansion.

SCOPE OF STUDY:

The report analyzes the Nuclear Medicine Radioisotope market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radioisotope Type (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123), Other Radioisotope Types); Application (Cardiology, Oncology, Neurology, Lymphoma, Thyroid, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • NTP Radioisotopes SOC Ltd.
  • Positron Corporation
  • Siemens Healthineers

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Nuclear Medicine Radioisotope - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Cancer and Cardiovascular Diseases Spurs Strong Growth in the Nuclear Medicine Radioisotope Market
    • Technological Innovations in Radiopharmaceuticals Expand the Addressable Market Opportunity for Nuclear Medicine Radioisotopes
    • Aging Population and Rising Life Expectancy Worldwide Strengthen the Business Case for Greater Utilization of Radioisotopes in Healthcare
    • Expansion of PET-CT and SPECT Imaging Technology Propels Growth in Diagnostic Applications for Nuclear Medicine
    • Government Healthcare Initiatives and Infrastructure Modernization Projects Drive the Adoption of Nuclear Medicine Radioisotopes
    • Rising Demand for Minimally Invasive Diagnostic and Therapeutic Techniques Generates New Opportunities for Radioisotope-Based Solutions
    • Continuous Advancements in Cyclotron and Reactor Technologies Sustain Long-Term Growth in Global Radioisotope Production
    • Development of Targeted Radiotherapy Expands the Scope and Effectiveness of Therapeutic Nuclear Medicine Radioisotopes
    • Increased Focus on Precision Medicine and Personalized Treatments Strengthens Demand for Nuclear Medicine Radioisotopes in Oncology
    • Rising Incidence of Neurological and Neurodegenerative Disorders Accelerates Demand for Diagnostic Radioisotopes in Brain Imaging
    • Stringent Regulatory Approvals, Safety Protocols, and Licensing Challenges Present Barriers to Market Growth for Nuclear Medicine Radioisotopes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nuclear Medicine Radioisotope Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Iodine (I-123) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Radioisotope Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Radioisotope Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Radioisotope Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION